Investing

Arcellx : ACLX

ACLX

Stock Data

$115.07

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Arcellx Inc is a biotechnology firm based in Redwood City, California, focusing on innovative immunotherapies for cancer and other incurable diseases. Its flagship product, anitocabtagene autoleucel, is advancing through clinical trials to combat multiple myeloma. The company is also exploring treatments for acute myeloid leukemia and myelodysplastic syndrome through its pipeline of product candidates. Arcellx has formed a strategic partnership with Kite Pharma for the co-development and co-commercialization of its leading therapy. Originally known as Encarta Therapeutics, Arcellx was founded in 2014.

All Arcellx Articles

1 Article

Lee Jackson | Dec 22, 2025 at 8:12 AM EST

Here Are Monday’s Top Wall Street Analyst Research Calls: BlackSky Technology, Cummins, Lamb Watson, Ollie’s Bargain Outlet, Sealed Air, Volaris, and More

Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week after an outstanding…